William Wong

12PUBLICATIONS
24CO-AUTHORS
Molecular targetsNot-for-profit finance and riskPredictive and prognostic markersGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 01, 2025
Real-World Clinical Oncology Outcomes Associated with the Accelerated Approval Pathway.

Tu My To, Stacey Kowal, James D Chambers

|Dec 01, 2025
The unintended consequences of the inflation reduction act on biosimilar market incentives and Medicare savings.

Molly T Beinfeld, Priyanka Ghule, Fariel LaMountain

|Aug 05, 2025
State-level opportunities to advance biomarker testing in patients with advanced cancers and state-regulated plans.

William B Wong, Tu My To

|Jul 29, 2024
Biosimilar underutilization alone does not foretell a broken biologics market.

Fariel LaMountain, Molly T Beinfeld, William Wong

|Jan 26, 2024
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing Panels.

Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty

|Jan 23, 2024
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations.

William Wong, Stacey Kowal, Tu My To

Pageof 2

Frequent Collaborators

3 joint publications

Stacey Kowal

3 joint publications

Tu My To

2 joint publications

Fariel LaMountain

2 joint publications

Louis P Garrison